This finding is in agreement with recent studies that showed B55α protein expression increased after FTY720 treatment [25] and B55α knockdown by RNAi in an AML cell line rendered the cells resistant to FTY720 [26]. This evidence concerns the gene PPP2R2A and acute myeloid leukemia.